Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Maytansine

Related Products

Hot Products

Name

Maytansine

EINECS 252-754-7
CAS No. 35846-53-8 Density 1.32g/cm3
PSA 156.47000 LogP 3.92820
Solubility N/A Melting Point 183.5-184℃
Formula C34H46 Cl N3 O10 Boiling Point 895.1°Cat760mmHg
Molecular Weight 692.206 Flash Point 495.1°C
Transport Information N/A Appearance N/A
Safety A deadly poison by intraperitoneal and intravenous routes. Moderately toxic by subcutaneous route. Human systemic effects by intravenous route: hallucinations, distorted perceptions, change in motor activity, and nausea or vomiting. An experimental teratogen. Mutation data reported. Used as an antineoplastic agent. When heated to decomposition it emits very toxic fumes of Cl and NOx. Risk Codes N/A
Molecular Structure Molecular Structure of 35846-53-8 (maitansine) Hazard Symbols N/A
Synonyms

L-Alanine, N-acetyl-N-methyl-,11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-ylester, [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-;Maitansine;Maysanine;Maytansin;N-Acetyl-N-methyl-L-alanine [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-ylester;NSC 153858;

Article Data 3

Maytansine Synthetic route

64817-73-8

maytansine 9-O-methyl ether

35846-53-8

maytansine

Conditions
ConditionsYield
With pyridine hydrochloride In tetrahydrofuran at 25℃; for 14h;95%
75340-67-9

4-deoxymaytansinol

35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
2: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
3: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
4: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
75349-70-1

(3E,5E,14E)-(7R,8S,12S,13S,16S)-21-Chloro-16-hydroxy-7,8,22-trimethoxy-3,13,15,19-tetramethyl-11-oxa-9,19-diaza-tricyclo[18.3.1.18,12]pentacosa-1(24),3,5,14,20,22-hexaene-10,18-dione

35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
2: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
3: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
75340-66-8

C36H56ClNO5S2Si

35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 1.) pyridine, 2.) aq. ammonium hydroxide / 1.) 27 deg C, 20 min, 2.) tert-butyl alcohol, 27 deg C, 2 h
2: mercuric chloride, aq. calcium carbonate / acetonitrile / 12 h / 25 °C
3: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
4: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
5: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
6: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
7: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
75349-69-8

3-O-(tert-butyldimethylsilyl)-4,5-deoxymaytansinol

35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
2: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
3: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
4: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
5: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
75349-68-7

C37H57ClN2O6S2Si

35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: mercuric chloride, aq. calcium carbonate / acetonitrile / 12 h / 25 °C
2: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
3: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
4: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
5: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
6: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme

C40H64ClNO6S2Si

35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 1.) 2-propanethiol, boron trifluoride etherate, 2.) silver nitrate, aq. 2,6-lutidine / 1.) methylene chloride, - 78 deg C, 5 min, 2.) THF, 25 deg C, 1.75 h
2: 1.) pyridine, 2.) aq. ammonium hydroxide / 1.) 27 deg C, 20 min, 2.) tert-butyl alcohol, 27 deg C, 2 h
3: mercuric chloride, aq. calcium carbonate / acetonitrile / 12 h / 25 °C
4: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
5: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
6: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
7: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
8: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme

(E)-(3S,6S,7S)-3-(tert-Butyl-dimethyl-silanyloxy)-8-{2-[(2E,4E)-(R)-6-(4-chloro-3-methoxy-5-methylamino-phenyl)-1-methoxy-5-methyl-hexa-2,4-dienyl]-[1,3]dithian-2-yl}-7-(2-methoxy-propoxy)-4,6-dimethyl-oct-4-enoatetetrabutyl-ammonium;

35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 71 percent / mesitylenesulfonyl chloride, diisopropylethylamine / benzene / 28 h / 40 °C
2: 1.) 2-propanethiol, boron trifluoride etherate, 2.) silver nitrate, aq. 2,6-lutidine / 1.) methylene chloride, - 78 deg C, 5 min, 2.) THF, 25 deg C, 1.75 h
3: 1.) pyridine, 2.) aq. ammonium hydroxide / 1.) 27 deg C, 20 min, 2.) tert-butyl alcohol, 27 deg C, 2 h
4: mercuric chloride, aq. calcium carbonate / acetonitrile / 12 h / 25 °C
5: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
6: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
7: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
8: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
9: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
2: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
67-56-1

methanol

35846-53-8

maytansine

64817-73-8

(3E,5E,7R,84Ξ,86S)-12c-(N-acetyl-N-methyl-L-alanyloxy)-14-chloro-10t,11c-epoxy-15,7r,84-trimethoxy-3,9c,11t,15-tetramethyl-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione

Conditions
ConditionsYield
With trifluoroacetic acid In benzene Ambient temperature;

Maytansine History

in 1972,Maytansine was first isolated  from the African plant, Maytenus ovatus (Celastraceae), later renamed Maytenus serrata,by Kupchan and co-workers in a yield of 0.2 mg/kg of dried plant material.

Maytansine Specification

Maytansine, with the CAS NO. 35846-53-8, is also called Maitansine; Maysanine; Maytansin. Maytansine is an ansamycin antibiotic originally isolated from the Ethiopian shrub Maytenus serrata. Maytansine binds to tubulin at the rhizoxin binding site, thereby inhibiting microtubule assembly, inducing microtubule disassembly, and disrupting mitosis.

Physical properties about Maytansine are: (1)ACD/LogP: 4.066; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): 4.07; (4)ACD/LogD (pH 7.4): 4.07; (5)ACD/BCF (pH 5.5): 724.76; (6)ACD/BCF (pH 7.4): 722.57; (7)ACD/KOC (pH 5.5): 3880.82; (8)ACD/KOC (pH 7.4): 3869.11; (9)#H bond acceptors: 13; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 7; (12)Index of Refraction: 1.59 ; (13)Molar Refractivity: 176.691 cm3; (14)Molar Volume: 523.775 cm3; (15)Polarizability: 70.046 10-24cm3; (16)Surface Tension: 57.5769996643066 dyne/cm; (17)Density: 1.322 g/cm3; (18)Flash Point: 495.133 °C; (19)Enthalpy of Vaporization: 136.306 kJ/mol; (20)Boiling Point: 895.091 °C at 760 mmHg

You can still convert the following datas into molecular structure:
(1)InChI=1S/C34H46ClN3O10/c1-18-11-10-12-26(45-9)34(43)17-25(46-32(42)36-34)19(2)30-33(5,48-30)27(47-31(41)20(3)37(6)21(4)39)16-28(40)38(7)23-14-22(13-18)15-24(44-8)29(23)35/h10-12,14-15,19-20,25-27,30,43H,13,16-17H2,1-9H3,(H,36,42)/b12-10-,18-11+/t19-,20+,25+,26-,27-,30-,33+,34+/m1/s1;
(2)InChIKey=WKPWGQKGSOKKOO-AQPVFDFWSA-N;
(3)SmilesC[C@@H]1[C@@H]2C[C@]([C@@H](/C=C\C=C(\Cc3cc(c(c(c3)OC)Cl)N(C(=O)C[C@H]([C@]4([C@@H]1O4)C)OC(=O)[C@H](C)N(C)C(=O)C)C)/C)OC)(NC(=O)O2)O;

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo intravenous 190ug/kg/5D (.19mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
Journal of the National Cancer Institute. Vol. 60, Pg. 93, 1978.
mouse LD50 intraperitoneal 245ug/kg (.245mg/kg)   National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986,
mouse LD50 intravenous 1530ug/kg (1.53mg/kg) BLOOD: THROMBOCYTOPENIA

BLOOD: LEUKOPENIA

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
National Technical Information Service. Vol. PB82-165507,
rat LD50 subcutaneous 480ug/kg (.48mg/kg)   Cancer Treatment Reports. Vol. 61, Pg. 1333, 1977.
rat LD50 subcutaneous 480ug/kg (.48mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Cancer Treatment Reports. Vol. 61, Pg. 1333, 1977.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 35846-53-8